I. Introduction: point of care blood analyzers in veterinary practice

In veterinary medicine, a point of care blood analyzer refers to a compact diagnostic system capable of delivering hematology results directly within the clinic or near the patient, rather than relying solely on central laboratories. In recent years, the concept has expanded from simple complete blood count (CBC) testing to multi-modal platforms that combine hematology, urine, feces, and immunoassay analysis in one device for small animal practice. This evolution is closely linked to advances in AI-based morphology, single-use test kits, and integrated workflows that aim to make near-patient diagnostics more comprehensive and easier to operate.

As part of this shift toward integrated veterinary diagnostics, point of care blood analyzer platforms are increasingly designed to combine analytical depth with practical usability in clinics and mobile settings. In this context, veterinary analyzers from Ozelle’s veterinary diagnostics portfolio illustrate how AI-driven morphology and multi-channel testing can reshape everyday workflows without relying exclusively on large central laboratories.

II. Technology evolution: from single-parameter tests to AI-driven morphology

Traditional veterinary hematology analyzers originally focused on basic CBC parameters, providing counts for white blood cells, red blood cells, hemoglobin, and platelets to support routine screening. As case complexity and expectations grew, systems evolved toward 7-diff hematology analysis, differentiating white cell populations and expanding the parameter set for more nuanced interpretation. This shift laid the foundation for modern point of care blood analyzers that embed morphology and extended parameters directly at the bedside or in the exam room.

The next step in this evolution is the integration of AI-based morphology recognition, capable of identifying multi-classified and abnormal cells such as RET, SPH, and ETG in veterinary samples. Instead of relying solely on numerical outputs, AI morphology uses image data to classify cells like NST, NSG, NSH, RET, SPH, and ETG, offering richer insight into hematopoietic activity, hemolytic processes, and other pathological changes. For clinics adopting an advanced point of care blood analyzer, this means morphological detail that previously required manual smear review can now be generated as part of a standardized workflow.

III. Core features of veterinary point of care blood analyzers

III.1 Multi-functional integration: blood, urine, feces and immunoassay

A key characteristic of the latest veterinary point of care blood analyzer platforms is multi-functional integration across hematology, urine, feces, and immunoassay testing modules. The EHVT-50, for example, supports 7-diff hematology, urine sediment and chemistry, fecal analysis, and a panel of immunoassay markers within one footprint. The EHVT-75 multi-functional analyzer for veterinary laboratories goes further by combining blood, urine, and feces modules into a single system, designed as a companion for handling multiple sample types while saving bench space.

This integrated approach impacts throughput and sample handling efficiency, particularly for clinics dealing with mixed diagnostic requirements in a single visit. Instead of sending samples to separate devices or external laboratories, veterinarians can configure workflows where hematology, urine, and fecal results are produced in parallel from the same point of care platform. The consolidation of testing capabilities into one analyzer reduces manual transfers and simplifies daily operations, which is especially relevant in small facilities where space and staff time are constrained.

III.2 AI-based cell morphology and image-supported evidence

AI-driven morphology is another defining feature of advanced veterinary point of care blood analyzers. Systems such as EHVT-50 veterinary AI lab analyzers employ AI-powered cell morphology analysis able to identify multi-classified and abnormal cells including RET (reticulocytes), SPH (spherocytes), and ETG (erythrocyte ghosts), among others. The EHVT-75 similarly integrates 7-diff blood analysis with high-resolution imaging that captures key cells such as NST, NSG, NSH, RET, ETG, and SPH, providing visualized evidence for diagnostic decisions.

Such image-supported evidence changes how clinicians interact with hematology data at the point of care. Instead of interpreting parameters purely numerically, veterinarians can review images that highlight abnormal cell morphologies, supporting more confident correlation with clinical signs and other test results. These AI-generated images can also aid communication with pet owners, illustrating blood cell changes in a format that is easier to understand during consultation.

III.3 Maintenance-free workflows and single-use test kits

Maintenance requirements are a critical consideration for any point of care blood analyzer deployed in busy veterinary settings. Both EHVT-50 and EHVT-75 emphasize maintenance-free or low-maintenance workflows through the use of individual, highly integrated test kits and a liquid-free internal structure. By using single-use cartridges, these analyzers reduce the need for daily cleaning of internal fluidics and minimize the risk of cross-contamination between samples.

For small clinics and mobile units, decreased maintenance translates into more stable uptime and simpler operational routines. Staff can focus on sample processing and interpretation rather than regular disassembly or complex washing procedures. From an economic and logistical perspective, single-use test kits also help standardize reagent handling and quality control, with dry-type QC cards providing an additional layer of assurance.

IV. Clinical parameters and diagnostic scope in veterinary point of care blood analyzers

IV.1 Hematology parameters and 7-diff CBM

The hematology channel in EHVT-50 offers 7-diff CBM with 42 parameters, covering core indices such as WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW-CV, RDW-SD, PLT, MPV, PDW, and PCT. It also includes extended morphological parameters like NST, NSG, NSH, RET, SPH, and ETG, allowing a more detailed characterization of white cell and red cell populations. These parameters collectively support evaluation of inflammatory responses, anemia types, platelet function, and bone marrow activity in canine and feline patients.

In a point of care blood analyzer context, having such a parameter set available immediately in the clinic allows veterinarians to stratify cases more accurately during the first visit. For example, distinguishing between regenerative and non-regenerative anemia can be aided by reticulocyte indices, while recognition of spherocytes can prompt investigation into immune-mediated hemolytic processes. The integration of these indices into AI-driven morphology enables a more consistent interpretation across operators and time.

IV.2 Urine and fecal analysis for comprehensive evaluation

The urine analysis module in EHVT-50 covers multiple categories including casts (e.g., HYA, RBC-C, GRA), cells (RBC, WBC, RTE, SEC, TEC), crystals (MAP, COMC, COD, CP, UAC, CYSC, CC, BIC), microorganisms (COS, BAC, SAC, FUN), and other elements such as fat droplets. In practice, this allows veterinarians to assess renal function, urinary tract inflammation, crystal formation, and potential infectious processes within a single point of care workflow.

Similarly, fecal analysis capabilities encompass parasite eggs (ALE, ANE, CEE, DIP, SPI, TIE, TRE), digestive function markers (STA, LFAT, PLA, AF), cells (RBC, WBC, EPC), microorganisms, and intestinal protozoa such as TRI and FLA. Combining these outputs with hematology results provides a broader clinical picture, particularly for gastrointestinal and systemic conditions that manifest across multiple organ systems. When embedded in a multi-functional point of care blood analyzer platform, these modules help standardize fecal and urine microscopy in routine practice.

IV.3 Immunoassay panels for targeted conditions

Beyond morphology and routine chemistries, immunoassay panels in EHVT-50 extend the diagnostic scope to targeted conditions. Inflammation markers such as cCRP and fSAA provide quantifiable measures of systemic inflammatory status, while pancreatitis-specific markers cPL and fPL support focused evaluation of pancreatic disease. Kidney disease markers including cSDMA, fSDMA, cCyS-C, and fCyS-C aid early detection of renal dysfunction, complementing urine and hematology findings.

The immunoassay menu also includes hormone tests (cortisol, T4, HbA1c, TSH, cProg, LH) and infectious disease markers such as FeLV Ag, FIV Ab, FCoV Ab, FPV Ag, CDV Ag, CPV Ag, and other assays relevant to feline and canine medicine. When these immunoassay results are interpreted together with hematology, urine, and fecal data from the same point of care platform, veterinarians can construct a more coherent diagnostic pathway without fragmenting testing across multiple systems.

V. Application scenarios: how veterinary point of care blood analyzers change workflows

V.1 General veterinary clinics and small animal hospitals

In general clinics and small animal hospitals, a point of care blood analyzer with multi-modal capabilities supports initial evaluation, follow-up monitoring, and chronic disease management within a single visit. A patient presenting with non-specific signs such as lethargy and weight loss can undergo hematology, urine, feces, and targeted immunoassay testing during the consultation, enabling more comprehensive case assessment without delay.

User-friendly interfaces, touch-screen displays, and auto-calibration functions reduce the training burden for staff and help maintain consistency across operators. For example, EHVT-50 features a 10.1-inch touch screen, automatic calibration, and built-in thermal printing, streamlining both operation and reporting. The multi-functional design of EHVT-75 supports clinics that require combined blood, urine, and feces analysis in compact spaces while maintaining AI morphology capabilities.

V.2 Emergency departments and critical care

Emergency and critical care units require rapid turnaround times for diagnostic data, making point of care blood analyzers particularly valuable. In acute scenarios such as hemorrhage, sepsis, or shock, fast access to 7-diff hematology, urine, and immunoassay markers can inform triage, fluid therapy, and medication choices. The ability to process multiple sample types in one device reduces the need to route specimens through different instruments or external labs during time-critical situations.

High-resolution morphology imaging and extended parameters also play a role in recognizing subtle changes that may impact prognosis in critical care. For example, detection of abnormal white cell morphology alongside elevated inflammatory markers can refine assessment of systemic infection, while platelet indices contribute to coagulation risk evaluation. By embedding these capabilities into a point of care system, clinics can support more nuanced decision-making without expanding their equipment portfolio.

V.3 Mobile units and decentralized veterinary testing

Mobile veterinary units and decentralized testing environments face unique constraints related to space, infrastructure, and maintenance. Compact, maintenance-light point of care blood analyzers with single-use test kits and dry-type QC are well suited to such settings. The EHVT-50’s reliance on individual test kits and auto-calibration reduces dependence on complex fluidics and frequent service visits, which may be difficult to coordinate in remote locations.

For mobile services, the capacity to perform hematology, urine, feces, and immunoassay tests on site can significantly improve the immediacy of care. Field-based screening for infectious diseases, organ function, and systemic inflammation becomes feasible within a single visit, supporting decision-making about referral or on-site treatment. Veterinary analyzers such as EHVT-50 and EHVT-75 thus form part of a broader decentralization trend in small animal diagnostics, where distributed point of care platforms complement reference laboratory resources.

VI. Data integration, connectivity and quality assurance

Connectivity and data management are important dimensions of point of care blood analyzer deployment. EHVT-50 supports communication through USB ports, LAN, and LIS interfaces, enabling integration into hospital information systems and centralized record platforms. This allows results from hematology, urine, feces, and immunoassay modules to be stored, reviewed, and trended alongside other clinical data for each patient.

Quality assurance in these systems is supported by auto calibration modes and dry-type quality control cards. Standardized QC procedures help maintain analytical reliability across different sites and operators, which is essential when point of care testing is adopted in multiple branches or mobile units. In combination with AI-based morphology and standardized report formats, these features contribute to consistent interpretation and reduce variability associated with manual methods.

VII. Future trends in veterinary point of care blood analyzers

Looking ahead, veterinary point of care blood analyzers are expected to evolve through expansion of AI morphology algorithms, additional immunoassay markers, and broader species coverage. As training datasets grow, AI systems may refine recognition of subtle cytological features and rare cell populations, further enhancing diagnostic value in clinics and laboratories. Development pipelines already hint at an extended test portfolio, including more cardiac, endocrine, and inflammatory markers tailored to diverse clinical scenarios in small animal medicine.

Multi-species compatibility beyond canine and feline, along with customizable test panels, will likely gain importance as practices seek tailored configurations for their patient base. At the same time, integration with digital platforms from providers such as Ozelle suggests a future where point of care devices form part of a connected veterinary diagnostic ecosystem, rather than standalone instruments. In that ecosystem, analyzers like EHVT-75 and EHVT-50 support distributed, morphology-rich testing across central and decentralized sites.

VIII. Conclusion: positioning point of care blood analyzers in veterinary diagnostics

Veterinary point of care blood analyzers have moved beyond single-parameter CBC devices into AI-enabled, multi-modal platforms that integrate hematology, urine, feces, and immunoassay testing in one system. AI-based morphology and extended parameters provide image-backed evidence and richer clinical context, while maintenance-free workflows and single-use test kits address practical constraints in clinics and mobile units.

Within this landscape, solutions such as EHVT-50 and EHVT-75 represent an approach where near-patient diagnostics are designed around integrated, standardized, and connected workflows rather than isolated instruments. As technology and test menus continue to develop, the role of the point of care blood analyzer in veterinary practice is likely to expand further, supporting more timely and data-rich decision-making across a range of clinical environments. Veterinary analyzers within Ozelle’s veterinary diagnostics portfolio exemplify this trend toward morphology-focused, multi-modal point of care platforms.